Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility
MicroRNAs are small, noncoding molecules of about twenty-two nucleotides with crucial
roles in both healthy and pathological cells. Their expression depends not only on genetic …
roles in both healthy and pathological cells. Their expression depends not only on genetic …
Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting
Lung cancer stands as the foremost health issue and the principal reason for mortality
worldwide. It is projected that India will see over 1.73 million new cases and more than …
worldwide. It is projected that India will see over 1.73 million new cases and more than …
The neem limonoid nimbolide modulates key components of the DNA damage response signalling in cellular and animal models of oral squamous cell carcinoma
S Arvindh, M Priyadarshini, AB Baba… - Current …, 2025 - benthamdirect.com
Background Deregulated DNA damage response (DDR) network is implicated in cancer
progression and therapy resistance. Objective The present study was designed to …
progression and therapy resistance. Objective The present study was designed to …
Integrative analysis of anoikis-related genes prognostic signature with immunotherapy and identification of CDKN3 as a key oncogene in lung adenocarcinoma
H Qin, Q Wang, J Xu, H Zeng, J Liu, F Yu… - International …, 2024 - Elsevier
Anoikis, a form of programmed cell death induced by loss of cell contact, is closely
associated with tumor invasion and metastasis, making it highly significant in lung cancer …
associated with tumor invasion and metastasis, making it highly significant in lung cancer …
Detecting mir-155-3p through a Molecular Beacon Bead-Based Assay
D Moreira, D Alexandre, A Miranda, P Lourenço… - …, 2024 - pmc.ncbi.nlm.nih.gov
Lung cancer (LC) is recognized as one of the most prevalent and lethal cancers worldwide,
underscoring an urgent need for innovative diagnostic and therapeutic approaches …
underscoring an urgent need for innovative diagnostic and therapeutic approaches …
Barbiturate Derivative JL1 Encapsulated with a Hafnium-Based MOF in Poly(N-isopropylacrylamide) for Non-Small Cell Lung Cancer Therapy
X Tian, L Yang, Q Li, Q Wu, H Jiang… - ACS Applied Nano …, 2025 - ACS Publications
Nonsmall cell lung cancer (NSCLC), which accounts for the majority of cancer-related
deaths globally, remains refractory to available therapies despite advancements in treatment …
deaths globally, remains refractory to available therapies despite advancements in treatment …
Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic …
M Lyu, L Luo, L Zhou, X Feng, J Yang, Z Xu… - Cancer Cell …, 2024 - Springer
Background The incidence of multiple primary cancers (MPC), especially involving primary
lung cancer (PLC) and primary hematologic malignancies (PHM), is rising. This study aims …
lung cancer (PLC) and primary hematologic malignancies (PHM), is rising. This study aims …
Beyond the Horizon: A Cutting-Edge Review of the Latest Checkpoint Inhibitors in Cancer Treatment
M Boutros, F Attieh, A Chartouni, J Jalbout… - Cancer …, 2023 - Taylor & Francis
Immune checkpoint inhibitors (ICIs) have emerged as a revolutionary paradigm in oncology,
offering a potent arsenal against various malignancies by harnessing the body's own …
offering a potent arsenal against various malignancies by harnessing the body's own …
[HTML][HTML] Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR …
J Kumbrink, MC Demes, J Jeroch… - Pathology and …, 2024 - ncbi.nlm.nih.gov
Lung cancer is a paradigm for a genetically driven tumor. A variety of drugs were developed
targeting specific biomarkers requiring testing for tumor genetic alterations in relevant …
targeting specific biomarkers requiring testing for tumor genetic alterations in relevant …
Recent advances in discovering molecular targets for cancer therapy
Z Yang, T Wang - Frontiers in Medicine, 2024 - frontiersin.org
As one of the main factors resulting in high morbidity and mortality worldwide, cancer is
threatening human health constantly. 19.3 million cancer-related cases were recorded …
threatening human health constantly. 19.3 million cancer-related cases were recorded …